Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

DetailsRelated

Reference 34 - Immediate Adverse Reactions to Gandolinium-Based MR Contrast Media

FDA-2026-P-6737-0036Supporting & Related Material
Document

Details

The document's own metadata, straight from the source system.

Title
Reference 34 - Immediate Adverse Reactions to Gandolinium-Based MR Contrast Media
Posted
Jun 15, 2026
Agency
Food and Drug Administration (FDA)
Topics
View on regulations.gov ↗